undecylenoyl phenylalanine

L-phenylalanine, N-(1-oxo-10-undecenyl)-

CAS: 175357-18-3 C20 H29 N O3 MW: 331.45573000

Identification

Nameundecylenoyl phenylalanine
CAS Number175357-18-3
FDA UNII271P08C6OD
Molecular FormulaC20 H29 N O3
Molecular Weight331.45573000

Regulatory

Physical Properties

Assay 95.00 to 100.00
Food Chemicals Codex Listed No
Soluble in water, 0.2348 mg/L @ 25 °C (est)

Cosmetic Information

CosIngcosmetic data
Cosmetic Usesskin conditioning

No sensory data available

Safety Information

Oral/Parenteral ToxicityNot determined
Dermal ToxicityNot determined
Inhalation ToxicityNot determined

GHS Classification

['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']

Safety in Use

Categorycosmetic ingredient for skin conditioning
Recommendation for undecylenoyl phenylalanine usage levels up tonot for fragrance use.
Recommendation for undecylenoyl phenylalanine flavor usage levels up tonot for flavor use.

BOC Sciences

Best of Chemicals Supplier

Quality supplier of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecul...

View All Website 1-631-485-4226 account@bocsci.com

Potential Uses

None Found

Natural Occurrence

not found in nature

Synonyms

(2S)-3- phenyl-2-[[(E)-undec-2-enoyl]amino]propanoic acid L- phenylalanine, N-(1-oxo-10-undecenyl)- PubMed: A double-blind vehicle-controlled study of a preparation containing undecylenoyl phenylalanine 2% in the treatment of melasma in females. PubMed: Efficacy of hydroquinone-free skin-lightening cream for photoaging. PubMed: Application of genomics to breakthroughs in the cosmetic treatment of skin ageing and discoloration. PubMed: Efficacy of a novel hydroquinone-free skin-brightening cream in patients with melasma. PubMed: Reduction in the appearance of facial hyperpigmentation by topical N-undecyl-10-enoyl-L-phenylalanine and its combination with niacinamide. PubMed: A randomized, double-blind, vehicle-controlled study of a preparation containing undecylenoyl phenylalanine 2% in the treatment of solar lentigines.